Inventor · disambiguated record
Takuto Kojima
Also filed as: KOJIMA TAKUTO
27 granted patents·7 pending applications·83 citations·filing 2007–2024
95Inventor score
Top patents by PatentIndex Score
34 records- 0195US9878989B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jan 30, 2018·7 cites·2 claims
- 0293US10087150B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Oct 2, 2018·5 cites·2 claims
- 0393US9718814B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Aug 1, 2017·5 cites·2 claims
- 0493US9714241B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jul 25, 2017·5 cites·2 claims
- 0593US9487511B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Nov 8, 2016·5 cites·2 claims
- 0692US10428056B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Oct 1, 2019·4 cites·2 claims
- 0791US10548899B2Quinazolinone and benzotriazinone compounds with cholinergic muscarinin M1 receptor positive allosteric modulator activityTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Feb 4, 2020·7 cites·11 claims
- 0890US10323027B22,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptorTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jun 18, 2019·4 cites·6 claims
- 0989US10577382B2Fused heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Mar 3, 2020·3 cites·11 claims
- 1089US10053456B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Aug 21, 2018·3 cites·7 claims
- 1188US10435399B2HDAC6 inhibitory heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Oct 8, 2019·5 cites·17 claims
- 1288US9751885B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Sep 5, 2017·15 cites·10 claims
- 1386US2024317733A1Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1485US10899752B22,3-dihydro-4H-1,3-benzoxazin-4-one derivatives as modulators of cholinergic muscarinic M1 receptorTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Jan 26, 2021·1 cites·11 claims
- 1584US10696651B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jun 30, 2020·3 cites·9 claims
- 1682US10208046B2Nitrogen-containing heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Feb 19, 2019·4 cites·14 claims
- 1781US9777005B2Bicyclic heterocyclic compound containing a substituted pyrrole ringTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Oct 3, 2017·5 cites·12 claims
- 1876US10981934B2Fused heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Apr 20, 2021·1 cites·5 claims
- 1975US10968213B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Apr 6, 2021·0 cites·1 claims
- 2075US2021179603A1Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 2174US10519110B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Dec 31, 2019·1 cites·5 claims
- 2270US11390634B2Fused heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jul 19, 2022·0 cites·10 claims
- 2370US10414761B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 17, 2019·0 cites·1 claims
- 2466US9920047B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Mar 20, 2018·0 cites·1 claims
- 2563US2024309016A1Macrocyclic heterocycle compounds and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 2662US2024217957A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 2760US8785460B2Tricyclic compounds and use thereofASO KAZUYOSHI·Filed 2009·Granted Jul 22, 2014·0 cites·13 claims
- 2857US8901141B2Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing themASO KAZUYOSHI·Filed 2009·Granted Dec 2, 2014·0 cites·5 claims
- 2956US2023037538A1Anti-als compoundsTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 3053US2022370491A1Nucleic acid complexUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2020·Application pending·0 cites
- 3152US10676461B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Jun 9, 2020·0 cites·5 claims
- 3251US10189785B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jan 29, 2019·0 cites·8 claims
- 3349US12084436B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Sep 10, 2024·0 cites·16 claims
- 3443US2010056515A1Benzimidazole compoundsASO KAZUYOSHI·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Takuto Kojima files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →